Publications by authors named "E M Eed"
Article Synopsis
- * Various tests were conducted on rats to compare the healing effects of a herbal decoction against standard treatments and controls, with results showing significant improvement in wound healing for those treated with the decoction.
- * The findings indicated that the herbal decoction not only promoted better healing but also had antibacterial properties without any toxic effects, suggesting it could be a safe and effective household remedy for wounds.
Objective: Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. Hepatitis E infection is commonly widespread by the fecal oral routes and contaminated water. This study was designed to explore the prevalence and risk factors of hepatitis E infection in pregnant women of the Multan district, Pakistan.
View Article and Find Full Text PDFArticle Synopsis
- Hepatitis C virus (HCV) chronic infection can lead to severe liver diseases, and in the Middle East, genotype 4 is the most common strain, impacting treatment effectiveness.
- * A study involving 200 patients in Saudi Arabia found that 97.5% achieved a sustained virologic response (SVR12) after treatment with direct-acting antiviral drugs (DAAs), with no significant response differences based on age, gender, or HCV genotype.
- * However, the presence of cirrhosis and gender were identified as independent factors that could negatively influence reaching the SVR12 outcome.
Background and Objectives: Following an injury, upper-body strength and proprioception training is typically suggested. To our understanding, no prior research has looked into the impact of balance training on upper-body strength and stability. So, this study investigated the effects of Biodex balance training on enhancing the dynamic stability, strength, and function of the upper quarter (UQ) in recreational weightlifters.
View Article and Find Full Text PDFBackground: This study evaluates the seroprevalence of immunoglobulin M (IgM) and G (IgG) antibodies against SARS-CoV-2 after two doses of Pfizer-BioNTech COVID-19 vaccination from women with breast cancer in Jazan city Kingdom of Saudi Arabia, antibody detections were performed one month and three months after the administration of the second dose.
Methods: Overall, 103 breast cancer patients were included. Individuals who had had two doses of Pfizer-BioNTech vaccine, patients who were earlier diagnosed with COVID-19 infection, had not finalized immunization plan, or who received the second dose recently were excluded from the study.